Page last updated: 2024-08-23

alovudine and Thoracic Neoplasms

alovudine has been researched along with Thoracic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bares, R; Dittmann, H; Dohmen, BM; Eichhorn, K; Eschmann, SM; Horger, M; Machulla, HJ; Paulsen, F; Wehrmann, M1
Cameron, RB; Czernin, J; Fishbein, MC; Phelps, ME; Schiepers, C; Weber, WA; Yap, CS1

Trials

1 trial(s) available for alovudine and Thoracic Neoplasms

ArticleYear
[18F]FLT PET for diagnosis and staging of thoracic tumours.
    European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:10

    Topics: Adult; Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed

2003

Other Studies

1 other study(ies) available for alovudine and Thoracic Neoplasms

ArticleYear
Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography.
    Chest, 2006, Volume: 129, Issue:2

    Topics: Aged; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thoracic Neoplasms

2006